AP NEWS

Verastem Oncology to Present at Upcoming Investor Conferences

September 27, 2018

BOSTON--(BUSINESS WIRE)--Sep 27, 2018--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the Company will present at the following upcoming investor conferences:

The Cantor Fitzgerald Global Healthcare Conference on Tuesday, October 2, 2018 at 4:00pm EDT in New York City, NY, USA The Leerink Partners Roundtable Series: Rare Disease & Oncology on Wednesday, October 3, 2018 at 8:00am EDT in New York City, NY, USA

A live webcast of each presentation will be available on the investors section of the Company’s website at www.verastem.com. An archived presentation will be available for 90 days.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a commercial biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. We are driven by the strength, tenacity and courage of those battling cancer – single-minded in our resolve to deliver new therapies that not only keep cancer at bay, but improve the lives of patients diagnosed with cancer. Because for us, it’s personal.

Our first FDA approved product is now available for the treatment of patients with certain types of indolent non-Hodgkin’s lymphoma (iNHL). Our pipeline comprises product candidates that seek to treat cancer by modulating the local tumor microenvironment. For more information, please visit www.verastem.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005885/en/

CONTACT: Verastem Oncology:

Brian Sullivan, +1 781-469-1636

Senior Director, Corporate Development

bsullivan@verastem.com

or

Media:

FleishmanHillard

Adam Silverstein, +1 917-697-9313

media@verastem.com

or

Investors:

Argot Partners

Joseph Rayne, +1 617-340-6075

joseph@argotpartners.com

KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL GENERAL HEALTH

SOURCE: Verastem, Inc.

Copyright Business Wire 2018.

PUB: 09/27/2018 04:05 PM/DISC: 09/27/2018 04:05 PM

http://www.businesswire.com/news/home/20180927005885/en

AP RADIO
Update hourly